Published today - Advanced Access European Heart Journal

Slides:



Advertisements
Similar presentations
Oxford University Press Journals Collection Online.
Advertisements

A single dose of erythropoietin in ST-elevation myocardial infarction by Adriaan A. Voors, Anne M.S. Belonje, Felix Zijlstra, Hans L. Hillege, Stefan D.
© Children’s Ministry Today
Holiday Hearts
Long-term compliance with beta-blockers, angiotensin- converting enzyme inhibitors, and statins after acute myocardial infarction by Gunnar H. Gislason,
Ian Graham et al. European Heart Journal 2007;28:
Substrate and Trigger Ablation for Reduction of Atrial Fibrillation (STAR AF): a randomized, multicentre, international trial by Atul Verma, Roberto Mantovan,
The EKG Diagrams from Dubin, Dale Rapid Interpretation of EKG'x Third Ed. Cover Publ Co. Tampa, FL.
Abnormal Sinus Rhythms
Endurance sport practice as a risk factor for atrial fibrillation and atrial flutter by Lluís Mont, Roberto Elosua, and Josep Brugada Europace Volume 11(1):11-17.
The Decision of Target of BANSMOM m Yumiko Kimezawa November 25, 2011RPS1.
Attraction of Rotors to the Pulmonary Veins in Paroxysmal Atrial Fibrillation: A Modeling Study Conrado J. Calvo, Makarand Deo, Sharon Zlochiver, José.
One year follow-up after cryoballoon isolation of the pulmonary veins in patients with paroxysmal atrial fibrillation by Yves Van Belle, Petter Janse,
Atrial Fibrillation and Heart Failure Andrew A. Grace, MB, PhD, FRCP Heart Failure Clinics Volume 9, Issue 4, (October 2013) DOI: /j.hfc
Global Burden of Atrial Fibrillation in Developed and Developing Nations Sumeet S. Chugh, Gregory A. Roth, Richard F. Gillum, George A. Mensah Global Heart.
New therapeutic target for the non-electrophysiological signaling in atrial fibrosis and fibrillation such as inflammation Naohiko Takahashi, Osamu Kume,
Dual-site right ventricular and left ventricular pacing in a patient with left ventricular systolic dysfunction and atrial fibrillation using a standard.
Level 2 - Session 1A Instructional Shift: Focus Using Focus to Plan Classroom Instruction.
Prospective randomized study comparing amiodarone vs. amiodarone plus losartan vs. amiodarone plus perindopril for the prevention of atrial fibrillation.
Catheter Ablation of Atrial Fibrillation by Roderick Tung, Eric Buch, and Kalyanam Shivkumar Circulation Volume 126(2): July 10, 2012 Copyright.
Recurrence of pulmonary vein conduction and atrial fibrillation after pulmonary vein isolation for atrial fibrillation: A randomized trial of the ostial.
Nikola Gjorgov, MD, Frank Provenier, MD, Luc Jordaens, MD 
Rationale and design of the FreezeAF trial: A randomized controlled noninferiority trial comparing isolation of the pulmonary veins with the cryoballoon.
Figure 2 The incidence of new onset AF, strokes, heart failure, and mortality according to the BMI (/ person-years). (Left: BMI
Atrioventricular (AV) Heart Block
New-onset Atrial Fibrillation Predicts Heart Failure Progression
Figure 1: Correlation of plasma ET-1 levels with LAD in patients with mitral valve disease. r is Pearson’s correlation coefficient. ET-1: endothelin 1;
Table 1 Baseline characteristics of mitral valve operated patientsaaAF, atrial fibrillation; LA, left atrium; LVEDD, left ventricular end-diastolic.
Figure 1 Flow chart of study selection.
(A) Atrial (RA) and ventricular (RV) electrograms from unipolar DDD pacemaker during atrial fibrillation (AF). AF appears as rapid atrial depolarizations.
C. ACC/AHA/ESC guidelines Role of anticoagulant therapy in AF
Overall burden of AF associated with higher risk of thromboembolism and ischemic stroke An analysis of the KP-RHYTHM study, in patients with paroxysmal.
(p for noninferiority = )
Meta-Analysis of Effects of Digoxin on Survival in Patients with Atrial Fibrillation or Heart Failure: An Update  Mate Vamos, MD, PhD, Julia Wiebke Erath,
Gregory Y.H. Lip, MD, Jonathan L. Halperin, MD, Hung-Fat Tse, MD, PhD 
Murray H. Kwon, MD  The Journal of Thoracic and Cardiovascular Surgery 
James R. Edgerton, MD, Cecile Mahoney, BS, Michael J
Changing axis deviation, paroxysmal atrial fibrillation and elevation of prostate-specific antigen during acute myocardial infarction  Salvatore Patanè,
Figure 1 Rates of complications and mortality during index admission for atrial fibrillation ablation for the overall ... Figure 1 Rates of complications.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.
The procedural journey for our cohort of patients with persistent atrial fibrillation. The procedural journey for our cohort of patients with persistent.
Respiratory rate trending as a cause for atrial lead noise: A first report in an implantable cardioverter-defibrillator patient  Isla McClelland, MD,
Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.
Take home figure The 38% of heart failure reduced ejection fraction (HFrEF) patients who recovered LVEF (HFrecEF) were more ... Take home figure The 38%
(A) Kaplan-Meier curve showing AF-free survival after a single procedure for patients grouped according to use of CT integration. (A) Kaplan-Meier curve.
The novel Kv1.5 channel blocker vernakalant for successful treatment of new-onset atrial fibrillation in a critically ill abdominal surgical patient 
Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.
Receiver operating characteristics curve of N-terminal pro-atrial natriuretic peptide plasma levels (dark line) and brain natriuretic peptide (dashed line)
Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.
© 2018 The Hartford. Classification: Internally Controlled
Imaging findings and complications of transcatheter interventional treatments via the inferior phrenic arteries in patients with hepatocellular carcinoma 
The care model of the Innovative Telemonitoring Enhanced Care Programme for Congestive Heart Failure is integrated within usual care. The care model of.
Overall burden of AF associated with higher risk of thromboembolism and ischemic stroke An analysis of the KP-RHYTHM study, in patients with paroxysmal.
Paroxysmal atrial fibrillation after insect sting
Left Atrial Fibrosis Assessed with Cardiac MRI in Patients with Paroxysmal and Those with Persistent Atrial Fibrillation More than two left atrial segments.
Figure 1 Grant agencies and charitable foundations supporting Plan S.
Pharmacological management of patients with newly discovered atrial fibrillation. Pharmacological management of patients with newly discovered atrial fibrillation.
Pharmacological management of patients with recurrent paroxysmal atrial fibrillation. Pharmacological management of patients with recurrent paroxysmal.
Adjusted prevalence of CHD, atrial fibrillation, and stroke by sex and ethnic group. Numbers for sex are adjusted for age and clustering within practices.
Pharmacological management of patients with recurrent persistent or permanent atrial fibrillation. Pharmacological management of patients with recurrent.
Commentary: Judgment day: Should you add atrial fibrillation ablation?
Distribution of systolic pulmonary artery pressure (Ppa) in relation to functional class (FC) for congenital heart disease patients with a) atrial septal.
Temporal classification of atrial fibrillation (AF).
Left atrial appendage flow during atrial fibrillation, as determined by pulsed Doppler during transoesophageal echocardiography. Left atrial appendage.
Temporal trends of AF hospitalisation per 100 patients with AF according to main hospitalisation causes between 2006 and *P value for increase trends 
Figure 1 ABCDE of primary prevention.2
The primary mechanism of action of colchicine is tubulin disruption and thus the inhibition of microtubule polymerisation, an essential component of cellular.
Survival free of atrial fibrillation after implantation of an implantable cardioverter defibrillator in our series (151 patients): overall population (solid.
Presentation transcript:

Published today - Advanced Access European Heart Journal

Classification of Atrial Fibrillation Paroxysmal (usually <48 h)

Time Course and Management of AF

Important Elements of the History

Symptom Scores

Diagnosis / Follow-up Class I Recommendations

Principles of Management

CHA 2 DS 2 -VASc

CHA 2 DS 2 -VASc Thromboembolic Risk Score

Selected OAC Recommendations

Bleeding Risk – HAS-BLED Score

Rate and Rhythm Control

Optimal Rate Control

Optimal Rate Control

Choice of Rate Control Medication

Antiarrhythmic Medication for Rhythm Control

Antiarrhythmic Medication for Rhythm Control

Antiarrhythmic Medication for Rhythm Control

Choice of AAD - Underlying Pathology

Catheter Ablation for Atrial Fibrillation

Indication for LA Catheter Ablation

Ablation when SHD is Present

“Upstream” Therapy Primary Prevention ACE inhibitors, Angiotensin receptor blockers, Aldosterone antagonists Statins, PUFAs Agents Considered:

“Upstream” Therapy – Secondary Prevention

Atrial Fibrillation in Athletes

European Heart Rhythm Association (EHRA); Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS)

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2024 SlidePlayer.com Inc. All rights reserved.